Skip to main content
. 2019 Dec 17;2019:6490820. doi: 10.1155/2019/6490820

Figure 2.

Figure 2

Cadmium concentrations in blood (Cd-B) following 90-day oral exposure to CdCl2 or 17β-estradiol (positive control), at the 90-day and 180-day postexposure periods. p ≤ 0.05 (a—vs. pure control group, b—vs. oil control, and c—vs. positive control).